Healthcare
HIMS Stock Analysis
Hims & Hers Health, Inc. · current price $28.82 (-8.96% today)
Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
★★★
Average
HIMS Stock AnalysisHims & Hers Health, Inc. · current price $28.82 (-8.96% today)
Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.
Reading HIMS’s price and volume history…
Checking the areas that decide this thesis…
AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.
Reading HIMS’s filings…
| Quarter | EPS | Est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | $0.29 | $0.23 | +26.2% | Beat |
| 2025-09-30 | $0.06 | $0.10 | -41.0% | Miss |
| 2025-12-31 | $0.08 | $0.04 | +92.5% | Beat |
| 2026-06-30 | $-0.37 | $-0.05 | -640.0% | Miss |
Hims & Hers Health, Inc. (HIMS) currently has a TickerMover Quant Score of 57/100, rated ★★★ Average. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.
TickerMover does not give buy or sell recommendations. HIMS scores 57/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.
HIMS's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.
Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.
Open the dashboard for HIMS →
